GelStat Corp. (GSAC)

Market Cap	1.20M
Revenue (ttm)	212.38K
Net Income (ttm)	-346.05K
Shares Out	2.99B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,345,523
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0002 - 0.0006
Beta	1.99
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialt...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: GSAC

Financial Performance

In 2023, GelStat's revenue was $149,527, an increase of 6309.22% compared to the previous year's $2,333. Losses were -$210,111, -72.40% less than in 2022.